GlassScriptPhysician profile
Michael Adelard Carron
NPI 1568670156
$22,363.27
in general payments reported to CMS, 2019-2025
26 companies · $14K in 2025
The $14K reported for 2025 was more than what 97% of Otolaryngology providers received nationally (typical 2025 total: $317).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $5,382 · 2020: $1,584 · 2021: $183 · 2022: $243 · 2023: $540 · 2024: $578 · 2025: $14K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $9,750 · Travel and Lodging: $3,087 · Food and Beverage: $1,898 · Consulting Fee: $220 · Education: $15.96.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $9,750.00 |
| Travel and Lodging | $3,087.22 |
| Food and Beverage | $1,897.75 |
| Consulting Fee | $220.00 |
| Education | $15.96 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Microaire Surgical Instruments LLC | $19,243.38 | 2019-2025 | |
| Optinose US, INC. | $712.25 | 2019-2025 | |
| Biotissue Holdings INC. | $466.24 | 2025 | |
| Medtronic, INC. | $290.00 | 2022-2024 | Straightshot, Merocel, Nuvent |
| Stryker Corporation | $256.42 | 2019-2023 | Na, Smartlock, Vsp System, Vsp Cranial |
| Depuy Synthes Sales INC. | $230.68 | 2023-2025 | Trumatch, Matrixmandible |
| Kls-Martin L.P. | $201.97 | 2019-2025 | |
| Glaxosmithkline, LLC. | $162.55 | 2021-2025 | Nucala |
| Hologic Sales and Service, LLC | $157.66 | 2025 | Coolseal Generator, Aptima, Thinprep 2000 Processor |
| Genzyme Corporation | $109.57 | 2024-2025 | |
| Checkpoint Surgical, INC | $95.85 | 2019 | |
| Inspire Medical Systems, INC. | $53.18 | 2024 | Inspire |
| Regeneron Healthcare Solutions, INC. | $46.27 | 2023-2024 | Libtayo |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $43.83 | 2025 | Lifevest |
| Ucb, INC. | $39.80 | 2024 | Bimzelx |
Show all 26 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Zimmer Biomet Holdings, INC. | $37.89 | 2019-2025 | Traumaone |
| Solta Medical, A Division of Bausch Health US, LLC | $36.78 | 2022 | |
| Merck Sharp & Dohme LLC | $33.25 | 2023 | Keytruda |
| Mimedx Group, INC. | $27.43 | 2025 | |
| Ethicon US, LLC | $20.98 | 2019 | |
| Integra Lifesciences Corporation | $19.99 | 2021 | |
| Sumitomo Pharma America, INC. | $17.75 | 2025 | Myfembree |
| Smith+Nephew, INC. | $17.58 | 2021 | |
| Acera Surgical, INC. | $15.11 | 2025 | Restrata Wound Matrix |
| Astrazeneca Pharmaceuticals LP | $14.13 | 2025 | Tezspire |
| Aerin Medical INC. | $12.73 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Carron listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.